ENCEPH UK Study
Start date:March 2015 End date:
December 2015 (Close to recruitment) Co-ordinated by:
Brain Infections UK, University of Liverpool Main trial site:
http://www.encephuk.org/studies
To produce a predictive tool for HSV encephalitis based on the early clinical features, by comparing the clinical features of those with and without HSV encephalitis.
Aim
To produce a predictive tool for HSV encephalitis based on the early clinical features, by comparing the clinical features of those with and without HSV encephalitis.
Trial Design
A Prospective multi-centre cohort observational study.
Eligibility criteria (summary of )
Patients who present to the Emergency Department or Acute Medical Unit with suspected encephalitis
Chief Investigator
Professor Tom Solomon
Local PI
Dr Matt Reed
Research Team
EMERGE Research team in collaboration with the Acute Medical Unit (AMU), Critical Care and the Virology team at the RIE
Further information
For more information please refer to main trial website
Local PI
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Research Team
Polly Black
Senior Research Nurse
Julia Grahamslaw
Lead Research Nurse
More EMERGE Trials
The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.
The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.
This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.
Participants will be asked to return for 6 visits across 12 months to evaluate their health.
Across the UK the trial aims to recruit 10,260 volunteers.
If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh
COV_002 Vaccine Trial
The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.